Cannabis leaves with Stock Talk and Cannabis Report labels
(Source: File)

A leading multi-state cannabis company, announced an exclusive partnership with Raw Garden, a cultivator and producer of pure cannabis products balancing flavour and potency, to bring a suite of the California-based company’s premier products to New Jersey consumers.

cannabis, weed
(File photo.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Curaleaf reports solid growth and robust cash generation in Q3 2025

2 | Aurora Cannabis breaks medical cannabis net revenue record in Q2 2026

3 | TerrAscend reports revenue and profit lift in Q3 2025

4 | Cronos sees revenue and profit increase in Q3 2025


Top Cannabis Stocks Oct. 31 to Nov. 6, 2025

1. T.TLRY | 3,523 views | Tilray Brands Inc.
2. T.CURA | 3,087 views | Curaleaf Holdings Inc.
3. T.LABS | 2,032 views | Medipharm Labs Corp.
4. T.WEED | 1,543 views | Canopy Growth Corp.
5. T.OGI | 436 views | Organigram Global Inc.
6. C.TGIF | 424 views | 1933 Industries Inc.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.




More From The Market Online

Jones Soda brings Fallout’s Nuka-Cola flavours to life

Jones Soda (CSE:JSDA) is launching a Fallout “Vault-Dweller Variety” Pack featuring Nuka-Cola Quartz, Cranberry, and Quantum.

@ the Bell: Market sentiment improves despite uncertainty

Canadian equities flatlined on Friday as investors assessed ongoing developments in the Middle East. Meanwhile, oil...

Silver rally sends Nicola Mining on BC treasure hunt

Nicola Mining kicks off an 800-metre drilling program at its 2,200-hectare Treasure Mountain silver project in British Columbia.

Michael Gentile keen to separate dirt from discovery with new investor forum

While every junior mining company thinks it's in line for a discovery, only a select few deserve high investor conviction.